Sign in
4

Changes in Ownership

Wave Life Sciences, Inc. Filed Acc 0000899243-19-004467

Chief Financial Officer sold 1,298 shares at $36.84 ($47,818)

From the SEC's structured data for this filing

Trades in this filing

Regnante Keith · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-02-19 Sale : show line 1 in the form −1,298 $36.84 $47,818 15,686 D
Open-market sales · 1,298 sh · avg $36.84 · $47,818
Loading xslF345X03/doc4.xml…